Prime Medicine (PRME) Stock Chart & Stock Price History → [Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (From OIC) (Ad) Free PRME Stock Alerts $5.61 -0.11 (-1.92%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Prime Medicine Stock Price Performance5 Day Performance+0.72%1 Month Performance-2.09%3 Month Performance-23.05%6 Month Performance-17.56%Year-To-Date Performance-36.68% Receive PRME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. PRME Stock Chart for Sunday, May, 12, 2024 PRME Chart by TradingView Prime Medicine Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$5.72$5.61-1.92%$6.02$5.61402,474 shs$673.36 million05/09/2024$5.36$5.72+6.72%$5.81$5.34635,213 shs$686.57 million05/08/2024$5.57$5.36-3.77%$5.52$5.17644,003 shs$643.36 million05/07/2024$5.40$5.57+3.15%$5.59$5.25665,921 shs$668.57 million05/06/2024$5.59$5.40-3.40%$5.77$5.391.39 million shs$648.16 million05/03/2024$5.61$5.59-0.36%$6.09$5.45923,386 shs$670.97 million Get the Latest News and Ratings for PRME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$5.27$5.61+6.45%$5.72$5.12848,800 shs$673.37 million05/01/2024$4.92$5.27+7.11%$5.59$4.85813,055 shs$632.51 million04/30/2024$4.86$4.92+1.23%$5.11$4.631.20 million shs$590.50 million04/29/2024$4.43$4.86+9.83%$5.14$4.651.26 million shs$583.30 million04/26/2024$4.30$4.43+2.91%$4.65$4.16633,031 shs$531.09 million04/25/2024$4.70$4.30-8.51%$4.60$4.11848,905 shs$516.09 million04/24/2024$4.80$4.70-2.08%$4.93$4.69521,574 shs$564.09 million04/23/2024$4.78$4.80+0.42%$5.30$4.79850,784 shs$575.71 million04/22/2024$4.51$4.78+5.99%$4.91$4.381.45 million shs$573.31 million04/19/2024$4.59$4.51-1.74%$4.68$4.34926,800 shs$540.93 million04/18/2024$4.93$4.59-6.90%$4.98$4.56911,879 shs$550.53 million04/17/2024$5.27$4.93-6.45%$5.32$4.92652,428 shs$591.30 million04/16/2024$5.44$5.27-3.13%$5.41$5.17531,443 shs$632.08 million04/15/2024$5.73$5.44-5.06%$5.72$5.40612,271 shs$652.47 million04/12/2024$5.81$5.73-1.38%$5.86$5.65509,290 shs$687.26 million04/11/2024$5.89$5.81-1.36%$6.01$5.61588,597 shs$696.85 million04/10/2024$6.18$5.89-4.69%$6.02$5.78552,849 shs$706.45 million04/09/2024$6.10$6.18+1.31%$6.40$6.08442,638 shs$741.23 million04/08/2024$5.75$6.10+6.09%$6.17$5.82676,883 shs$731.63 million04/05/2024$5.79$5.75-0.69%$5.91$5.48838,701 shs$689.66 million04/04/2024$5.80$5.79-0.17%$6.04$5.721.01 million shs$694.45 million04/03/2024$6.32$5.80-8.23%$6.45$5.791.26 million shs$695.65 million04/02/2024$6.76$6.32-6.51%$6.61$6.181.72 million shs$758.02 million04/01/2024$7.00$6.76-3.43%$7.05$6.61543,429 shs$810.79 million03/29/2024$7.00$7.00$7.06$6.71641,726 shs$839.58 million03/28/2024$6.76$7.00+3.55%$7.06$6.71641,716 shs$839.58 million03/27/2024$6.66$6.76+1.50%$6.96$6.60703,541 shs$810.79 million03/26/2024$6.87$6.66-3.06%$7.10$6.50593,473 shs$798.80 million03/25/2024$6.93$6.87-0.87%$7.09$6.86293,897 shs$823.99 million03/22/2024$7.34$6.93-5.59%$7.34$6.91393,936 shs$831.18 million03/21/2024$7.37$7.34-0.41%$7.59$7.18295,078 shs$880.36 million03/20/2024$7.11$7.37+3.66%$7.51$6.80335,754 shs$883.95 million03/19/2024$7.02$7.11+1.28%$7.28$6.90341,810 shs$852.77 million03/18/2024$7.16$7.02-1.96%$7.22$6.71391,182 shs$841.98 millionShocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company03/15/2024$6.89$7.16+3.99%$7.20$6.62977,321 shs$858.76 million03/14/2024$7.93$6.89-13.18%$7.86$6.771.03 million shs$825.79 million03/13/2024$7.71$7.93+2.85%$8.07$7.64497,684 shs$951.12 million03/12/2024$8.03$7.71-3.99%$8.14$7.62456,650 shs$924.74 million03/11/2024$8.08$8.03-0.62%$8.35$8.00347,580 shs$963.12 million03/08/2024$8.14$8.08-0.74%$8.58$8.02377,199 shs$969.12 million03/07/2024$8.42$8.14-3.33%$8.54$8.04431,345 shs$976.31 million03/06/2024$8.07$8.42+4.40%$8.55$8.14529,044 shs$1.01 billion03/05/2024$8.77$8.07-8.04%$8.88$7.90614,902 shs$784.89 million03/04/2024$8.74$8.77+0.34%$8.91$8.25608,864 shs$853.50 million03/01/2024$8.63$8.74+1.27%$9.06$8.71618,188 shs$850.61 million02/29/2024$9.18$8.63-5.99%$9.57$8.60712,255 shs$839.87 million02/28/2024$9.39$9.18-2.24%$9.45$9.07533,027 shs$893.40 million02/27/2024$8.66$9.39+8.43%$9.77$8.82974,979 shs$913.84 million02/26/2024$8.32$8.66+4.09%$8.86$8.17430,041 shs$842.79 million02/23/2024$8.45$8.32-1.54%$8.73$7.92433,552 shs$809.70 million02/22/2024$8.49$8.45-0.47%$8.86$8.03715,922 shs$822.35 million02/21/2024$8.03$8.49+5.73%$8.63$8.08593,076 shs$826.25 million02/20/2024$8.46$8.03-5.08%$8.65$7.741.04 million shs$781.48 million02/19/2024$8.46$8.46$8.56$7.501.41 million shs$823.33 million02/16/2024$7.80$8.46+8.46%$8.56$7.501.41 million shs$823.33 million02/15/2024$6.87$7.80+13.62%$7.95$6.345.34 million shs$759.13 million02/14/2024$6.62$6.87+3.70%$6.97$6.51492,697 shs$668.10 million02/13/2024$7.29$6.62-9.19%$6.95$6.55585,900 shs$644.26 million02/12/2024$6.74$7.29+8.16%$7.33$6.76678,333 shs$709.46 million Related Companies: Novavax Stock Price Chart HilleVax Stock Price Chart Cabaletta Bio Stock Price Chart Kyverna Therapeutics Stock Price Chart Exscientia Stock Price Chart Humacyte Stock Price Chart Valneva Stock Price Chart Allogene Therapeutics Stock Price Chart ProKidney Stock Price Chart Alector Stock Price Chart Receive PRME Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:PRME) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.